Reliance Life Sciences is a research-driven organization developing business opportunities in bio-therapeutics (plasma proteins, biosimilars and novel proteins), pharmaceuticals (later-generation, oncology generics), clinical research services, regenerative medicine (stem cells therapies) and molecular medicine.
Reliance Life Sciences is part of the Promoter Group of Reliance Industries Limited.
Reliance Life Sciences has launched five of the world’s first biosimilars, has the largest number of biosimilars in the market in India, and the highest number of biosimilars under development globally. It has the distinction of being the first integrated manufacturer of plasma proteins in South Asia. Reliance Life Sciences has catalyzed the emergence of regenerative medicine in the country, and has the highest experience with cord blood stem cell transplants in India. RLS is one of the few centres in the world offering a specialized range of tests in molecular medicine and molecular genetics.
ABB India has won a significant automation contract from Reliance Life Sciences (RLS) to automate their new manufacturing plants in Nashik, Maharashtra. RLS is establishing manufacturing facilities for plasma proteins, biopharmaceuticals, oncology pharmaceuticals, and vaccines at its 160-acre Nashik facility.
Large-scale biotechnology production comes with complex process and automation challenges. ABB’s System 800xA® solution reduces manufacturing errors and ensures high-quality yields while adhering to strict regulatory guidelines.